Gain Therapeutics, Inc. - Common Stock — Stato Patrimoniale (NASDAQ:GANX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 38.99 M24.1 M18.61 M12.12 M22.82 M Totale passività 4.17 M5.22 M6.03 M4.78 M4.25 M Patrimonio netto totale 34.82 M18.88 M12.58 M7.34 M18.56 M Totale passività e patrimonio netto 38.99 M24.1 M18.61 M12.12 M22.82 M Debito totale 590.47 K495.26 K449.05 K328.33 K400.95 K Indebitamento netto 590.47 K495.26 K-16.35 M328.33 K-20.54 M

Notizie

Gain Therapeutics mantiene il rating Outperform di Oppenheimer

Gain Therapeutics presenta i dati della fase 1b sul farmaco per il Parkinson

Gain Therapeutics supera le stime sulle perdite nel Q1, azioni in rialzo del 3%

H.C. Wainwright conferma il rating Buy su Gain Therapeutics

Gain Therapeutics presenta dati sui biomarcatori dallo studio sul Parkinson

Gain Therapeutics riporta riduzione dell’81% in biomarcatore del Parkinson

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Roth/MKM alza il target di prezzo delle azioni Gain Therapeutics a $10

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?